Treace Medical Concepts, Inc. (TMCI)

10.38 +0.08 (+0.78%) 市場開市。 截至 01:20PM EDT。

Treace Medical Concepts, Inc.

100 Palmetto Park Place
Ponte Vedra, FL 32081
United States
904 373 5940
https://www.treace.com

版塊: Healthcare
行業: Medical Devices
全職員工: 516

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. John T. Treace	CEO, Founder & Director	1.09M	無	1972
Mr. Mark L. Hair CPA	Chief Financial Officer	599.7k	無	1970
Mr. Aaron J. Berutti	Senior Vice President of Sales	484.22k	無	1979
Mr. Terry W. Lubben	Senior Vice President of Operations	無	無	1965
Mr. Taylor Erickson	Chief Information & Security Officer	無	無	無
Ms. Julie D. Dewey	Chief Communications & Investor Relations Officer	無	無	1961
Mr. Scot M. Elder J.D.	Chief Legal & Compliance Officer and Corporate Secretary	無	無	1975
Mr. Nathan Minnich	Senior Vice President of Marketing	無	無	無
Mr. Daniel E. Owens	Chief Human Resources Officer	無	無	1972
Dr. Sean F. Scanlan Ph.D.	Chief Innovation Officer	無	無	1982

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

公司管治

截至 2024年4月1日 止，Treace Medical Concepts, Inc. 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中：6；董事會：9；股東權利：8；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。